Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2002

View Archived Issues

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

Altocor approved for hypercholesterolemia, deemed approvable for CHD

AGY raises funds to advance CNS drug programs

Bay-58-2667, a novel sGC activator with potential in cardiovascular diseases

Merger of Pfizer and Pharmacia will create industry giant

S1P3 antagonists identified at U. of Virginia

New hypolipidemic agent acts through PPARalpha receptor activation

Invisible Condom generally well tolerated in phase I clinical study

Potent HIV integrase inhibitor successfully completes preclinical testing

Preclinical data suggest utility of alpha2-adrenoceptor antagonist in PD

Novel guanylate cyclase activators in the Bayer pipeline

Cell adhesion inhibitors identified by Kowa team

Tularik and Roche present novel IKK modulators

Merck patents alpha5-selective GABA-A modulators for cognition disorders

New CB2 agonists and their use in autoimmune diseases, etc.

Acarbose delays development of type 2 diabetes

Sanofi-Synthelabo claims new PARP inhibitors in recent patent

Dietary intake of vitamin C and E may lower the risk of Alzheimer's disease

Capecitabine + docetaxel improves survival in advanced breast cancer

Serine protease inhibitors with anticoagulant activity described by Pharmacia

Eupolauridine targets fungal topoisomerase II, not topoisomerase I

Hematopoietic stem cell gene therapy combined with nonmyeloblative conditioning in ADA-SCID

Atridox to be studied in chronic periodontitis/heart disease trial

Alimta expanded access program cleared for malignant pleural mesothelioma

GenVec and DirectGene collaborate to develop targeted cancer therapies

Aromasin approved in Japan for postmenopausal breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...